Lilah's mother, Katelynn Smoot, has been sharing her daughter's story on social media for a long time, also drawing attention to the family's attempts to fundraise for her treatment.
Russian scientists have created a microfluidic platform that replicates blood flow in the brain. It is capable of supporting the vital activity of glioblastoma cells, one of the most aggressive forms of brain cancer that is difficult to treat.
Brain cancer presents a unique set of challenges for researchers because by the time a person develops symptoms, the tumours are sometimes so complicated that the fundamental mechanisms driving tumour growth are no longer easily identifiable. A research team led by Dr. Peter Dirks is aiming
A group of researchers from the University of Cincinnati has discovered a possible novel approach to enhance the efficacy of radiation therapy and enhance the prognosis of patients with lung cancer metastasizing to the brain.
According to a recent study, medications intended to treat blood and other malignancies may also increase the effectiveness of radiation therapy for low-grade brain tumours in adults.
Some children with autism face severe, long-term challenges such as developmental delays, social issues, and even the inability to communicate. Others report milder symptoms that improve with time.
Researchers revealed the function of a little-known junction between cells in the brain, which could have important treatment implications for conditions ranging from multiple sclerosis to Alzheimer's disease to glioma, a type of brain cancer.
The innovative device, which is the size and shape of a grain of rice, can perform hundreds of studies at the same time to examine the impact of novel treatments on some of the most difficult-to-treat brain tumours.
Researchers from Brigham and Women's Hospital, a founding member of the Mas
The new device, the size and shape of a grain of rice, can run dozens of trials at once to evaluate the impact of novel medicines on some of the most difficult-to-treat brain malignancies.
A recent study from the University of Michigan Department of Neurosurgery and Rogel Cancer Centre demonstrates encouraging preliminary findings that a therapy combining cell-killing and immune-stimulating drugs is safe and effective in extending survival for patients with gliomas, a particu
A study performed by UCLA Jonsson Comprehensive Cancer Centre researchers gave new light on why tumours that have spread to the brain from other parts of the body react to immunotherapy whereas glioblastoma, an aggressive brain cancer, does not.
Glioblastoma, the most prevalent and lethal type of brain cancer, spreads quickly, invading and destroying healthy brain tissue. The tumour shoots malignant tendrils into the brain, making surgical removal of the tumour extremely difficult or impossible.